Delivery Order SPE2DB24D2018-SPE2DB24FWUC4

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract, valued at $1,639.44, is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a delivery order contract awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,109.78, is for the delivery of Humalog 100 unit/ml insulin vials. The contract has a firm fixed price pricing type and an ultimate completion date of August 7, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA...
This is a $7,069.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication. The order has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of Humalog insulin vials, a prescription pharmaceutical product, to support U.S. government medical requirements. The contract has a firm-fixed price of $6,212.46 and an ultimate completion date of April 30, 2024. It is not a set-aside contract. Amerisourcebergen is a major supplier of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of Humalog 100 unit/mL vials in a 10 mL size. The contract, valued at $1,277.32, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the company. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) to provide a wide range of critical medical commodities,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humalog insulin vials. The $1,639.44 firm-fixed-price contract has a completion date of May 22, 2024. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,212.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. This is a firm fixed-price delivery order contract with a period of performance through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,947.76, is for the delivery of Humalog 100 Unit/mL Vial 10mL, a type of insulin medication. This is a firm fixed-price delivery order contract with a completion date of November 6, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. The $1,639.44 delivery order was awarded on May 16, 2024 by the Defense Logistics Agency (DLA), a Defense agency, and has an ultimate completion date of May 17, 2024. The contract is a firm fixed price delivery order with no set-aside designation. Amerisourcebergen...
This federal contract award, with the ID SPE2DB24D1107|SPE2DB24FZFP8, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract has a ceiling value of $1,639.44 and is a Firm Fixed Price Delivery Order type. The contract has an ultimate completion date of August 27, 2024 and does not utilize any set-aside designations....
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB24FWUC4
    Delivery Order

This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract for the supply of Humalog 100 Unit/mL insulin vials. The $1,092.96 contract has a firm fixed price and an ultimate completion date of August 23, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, generics, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs. The company holds several substantial Indefinite Delivery Contracts with the DLA and Department of Justice, valued up to $999,999,999 and $750,000, respectively, for delivering comprehensive pharmaceutical and medical supply solutions to federal agencies and beneficiaries nationwide.

Generated 11/21/24, 9:24 AM